Publication | Open Access
<p>JAM3 functions as a novel tumor suppressor and is inactivated by DNA methylation in colorectal cancer</p>
53
Citations
23
References
2019
Year
The findings indicated that JAM3 may be a novel tumor suppressor gene with epigenetic reduction in CRC and can be used as a potential noninvasive biomarker for CRC diagnosis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1